Subtypes of enteric neurons are coded by the neurotransmitters they synthesize, but it is not known whether enteric neuron subtypes might also be coded by other proteins, including calcium channel subtypes controlling neurotransmitter release. r What is the main finding and its importance?
Our data indicate that guinea-pig ileum myenteric neuron subtypes may be coded by calcium channel subtypes. We found that R-type calcium channels are expressed by inhibitory but not excitatory longitudinal muscle motoneurons. R-Type calcium channels are also not expressed by circular muscle inhibitory motoneurons. Calcium channel subtype-selective antagonists could be used to target subtypes of neurons to treat gastrointestinal motility disorders.
There is evidence that R-type Ca 2+ channels contribute to synaptic transmission in the myenteric plexus. It is unknown whether R-type Ca 2+ channels contribute to neuromuscular transmission. We measured the effects of the nitric oxide synthase inhibitor nitro-l-arginine (NLA), Ca 2+ channel blockers and apamin (SK channel blocker) on neurogenic relaxations and contractions of the guinea-pig ileum longitudinal muscle-myenteric plexus (LMMP) in vitro. We used intracellular recordings to measure inhibitory junction potentials. Immunohistochemical techniques localized R-type Ca 2+ channel protein in the LMMP and circular muscle. Cadmium chloride (pan-Ca 2+ channel blocker) blocked and NLA and NiCl 2 (R-type Ca 2+ channel blocker) reduced neurogenic relaxations in a non-additive manner. Nickel chloride did not alter neurogenic cholinergic contractions, but it potentiated neurogenic non-cholinergic contractions. Relaxations were inhibited by apamin, NiCl 2 and NLA and were blocked by combined application of these drugs. Relaxations were reduced by NiCl 2 or ω-conotoxin (N-type Ca 2+ channel blocker) and were blocked by combined application of these drugs. Longitudinal muscle inhibitory junction potentials were inhibited by NiCl 2 but not MRS 2179 (P2Y 1 receptor antagonist). Circular muscle inhibitory junction potentials were blocked by apamin, MRS 2179, ω-conotoxin and CdCl 2 but not NiCl 2 . We conclude that neuronal R-type Ca 2+ channels contribute to inhibitory neurotransmission to longitudinal muscle but less so or not all in the circular muscle of the guinea-pig ileum. 
Introduction
Non-adrenergic non-cholinergic (NANC) myenteric neurons are responsible for inhibitory neuromuscular transmission and muscle relaxation in the gastrointestinal (GI) tract. Pharmacological and electrophysiological studies have revealed that there are several inhibitory neurotransmitters released from NANC nerves and several postjunctional signalling mechanisms linked to smooth muscle relaxation. Inhibitory neuromuscular transmitters in the enteric nervous system (ENS) include nitric oxide (NO; Osthaus & Galligan, 1992; Sanders et al. 1992; He et al. 1993; Smits & Lefebvre, 1996) and one or more purinergic neurotransmitters (Crist et al. 1992; Smits & Lefebvre, 1996; Huang et al. 2001; Mutafova-Yambolieva & Durin, 2014; Mutafova-Yambolieva et al. 2007; Burnstock, 2008; Durnin et al. 2014) . The purinergic neurotransmitter acts at P2Y 1 receptors on GI smooth muscle (De Man et al. 2003; Gallego et al. 2006; Benkó et al. 2007; Wang et al. 2007 ) and platelet derived growth factor-α-positive fibroblast-like cells (Kurahashi et al. 2011 . P2Y 1 receptors link to Ca 2+ release from intracellular stores, and P2Y 1 receptor activation causes fast inhibitory junction potentials (IJPs) and relaxation (Gallego et al. 2006; Benkó et al. 2007; Wang et al. 2007; Zhang et al. 2010) . Inhibitory junction potentials result from Ca 2+ -induced activation of apamin-sensitive small-conductance Ca 2+ -dependent K + channels (SK channels; Crist et al. 1992; Pascuad et al. 1996; Wang et al. 2007; Zhang et al. 2010) . Nitric oxide production requires Ca 2+ -dependent activation of the neuronal isoform of nitric oxide synthase (nNOS; Sanders & Ward, 1992; Mashimo et al. 1996; Rekik et al. 1996; Rao et al. 2008) . Nitric oxide diffuses from inhibitory nerve terminals to target smooth muscle cells and interstitial cells of Cajal (ICCs; Burns et al. 1996; Suzuki et al. 2003) , where it activates soluble guanylate cyclase, causing cyclic guanosine 5 -triphosphate (cGMP) formation. The cGMP activates protein kinase G, which links to smooth muscle relaxation (Makhlouf & Murthy, 1997; De Man et al. 2007; Ilino et al. 2009; Lies et al. 2014 ).
The current model of the nerve pathways and connections in the guinea-pig ENS has two populations of inhibitory motoneurons supplying the circular muscle layer (Brookes, 1992) . These neurons have short projecting axons and are identified by the coexpression of vasointestinal polypeptide (VIP), NOS, enkephalin and GABA. The second class of inhibitory motoneuron supplying the circular muscle contains VIP, nNOS, neurofilament protein and gastrin-releasing peptide. These neurons have long projecting axons. There is only one class of inhibitory motoneuron supplying the longitudinal muscle, and these neurons contain VIP and nNOS (Brookes, 1992) . Inhibitory motoneurons provide a small fraction of the innervation of the longitudinal muscle layer as >90% of the nerve fibres in the longitudinal muscle layer are cholinergic (Brookes et al. 1992 ). This is not surprising, as IJPs are recorded rarely from the longitudinal muscle, unlike the circular muscle, in the guinea-pig ileum (Bywater & Taylor, 1986) . Inhibitory junction potentials occur frequently in the longitudinal muscle layer of the guinea-pig distal colon (Spencer & Smith, 2001; Spencer et al. 2003) .
Neurotransmitter release requires activation of voltage-gated Ca 2+ channels expressed by nerve terminals. R-Type (Ca V 2.3; Bian et al. 2004; Bian & Galligan, 2007) , N-type (Ca V 2.2), P/Q-type (Ca V 2.1), but not L-type (Ca V 1.2; Lundy & Frew, 1994; Cunningham et al. 1998; Kirchgessner & Liu, 1999; Takahashi et al. 1992; Reis et al. 2000 Reis et al. , 2002 Waterman, 2000) voltage-gated Ca 2+ channels contribute to neurotransmitter release from enteric neurons. R-Type Ca 2+ channels also couple to fast synaptic excitation in orally projecting pathways in the myenteric plexus, where acetylcholine is the excitatory neurotransmitter (Naidoo et al. 2010) . Fast synaptic excitation in descending pathways in the myenteric plexus uses acetylcholine and ATP as the excitatory neurotransmitters. These nerve terminals use N-and P/Q-type Ca 2+ channels to activate neurotransmitter release (Naidoo et al. 2010) . These data suggest that R-type Ca 2+ channels might be a marker for specific synapses in the myenteric plexus.
We tested the hypothesis that R-type Ca 2+ channels might be a marker for subsets of motoneurons supplying the longitudinal muscle layer and that R-type Ca 2+ channel blockers might selectively inhibit excitatory or inhibitory neuromuscular transmission in the guinea-pig ileum.
Methods

Ethical approval
All animal use protocols were reviewed and approved by the Institutional Animal Care and Use Committee at Michigan State University (animal use protocols 12/12-215-00 and 07/16-121-00). Animal use protocols were aligned with guidelines established by the Association for Assessment and Accreditation of Laboratory Animal Care and the United States Department of Agriculture. Adult male Hartley-strain guinea-pigs weighing 250-350 g (n = 40; 3 months of age) were purchased from Emergent BioSolutions, Lansing, MI, USA. Guinea-pigs and mice were anaesthetized using isoflurane inhalation (Abbott Laboratories, Chicago, IL, USA), followed by bilateral pneumothorax.
Longitudinal muscle-myenteric plexus (LMMP) preparation
The ileum was removed and placed in oxygenated (95% CO 2 , 5% CO 2 ) Krebs solution of the following composition (mM): 117 NaCl, 4.7 KCl, 2.5 CaCl 2 , 1.2 MgCl 2 , 1.2 NaH 2 PO 4 , 25 NaHCO 3 and 11 glucose. A glass rod was inserted into a 2 cm segment of the ileum, and the longitudinal muscle attached with the myenteric plexus (LMMP) was then teased off with a cotton swab soaked in Krebs solution. One end of the LMMP preparation was mounted with silk ligatures to a stationary hook at the bottom of a tissue holder and the other end connected to an isometric force transducer (FT03C; Grass Instruments, Quincy, MA, USA). The preparation was mounted in the longitudinal axis so that neurogenic contractions of the longitudinal muscle were recorded. The tissue holder also contained two platinum foil electrodes, and the LMMP preparations were positioned between the electrodes. The tissue holder and attached LMMP were placed in a 20 ml jacketed organ bath containing oxygenated Krebs solution at 37°C. A resting tension of 1 g was applied to each of four 2 cm segments of LMMP preparations. Tissues were allowed to equilibrate for 60 min, during which the Krebs solution was replaced at 15 min intervals.
Transmural electrical field stimulation
To study inhibitory mechanisms in the LMMP, each tissue sample was first precontracted with histamine (1 μM) to induce sustained baseline resting tension. Relaxation responses were expressed as a percentage decrease in histamine-induced tone. Neurogenic relaxations (in the presence of 1 μM scopolamine) were induced by brief trains of transmural electrical stimuli (20 Hz, 0.5 ms pulse duration, 1 s train duration, 0.25 Hz train rate, 45 mA) using a constant-current unit (Stimu-Splitter II; Med-Lab, Loveland, CO, USA). To determine the action of antagonists on relaxations, non-cumulative concentration-response curves were created, with a 15 min interval between successive doses.
Single electrical stimuli (0.1 Hz, 0.5 ms, 45 mA) were used to evoke neurogenic cholinergic contractions (scopolamine-free Krebs solution). Trains of stimuli (20 Hz, 1 s, 0.5 ms pulse duration, 45 mA, 0.25 Hz train rate) were used to evoke non-cholinergic contractions (in the presence of 1 μM scopolamine). To test the effect of antagonists on both kinds of contractions, non-cumulative concentration-response curves were created, with a 15 min interval between addition of successive antagonist concentrations.
Transmural electrical stimuli were provided by a Grass S48 stimulator, and mechanical activity of the LMMP was recorded using Labscribe software (iWorx, Dover, NH, USA) and a personal computer.
Intracellular electrophysiological recordings
A 1.5 cm section of the ileum was cut open along the mesenteric border and pinned flat in a silicone elastomer-lined (Sylgard; Dow Corning, Midland, MI, USA) Petri dish containing Krebs solution. The Krebs solution contained scopolamine (1 μM) and nifedipine (1 μM) to block muscarinic receptors and L-type Ca 2+ channels on smooth muscle cells, respectively. The submucosa was removed to expose the LMMP. A 5 mm 2 section of the LMMP was then transferred to a smaller silicone elastomer-lined recording chamber (2 ml), with the circular muscle layer facing up. When recording from circular muscle cells, the circular muscle layer was left intact. When longitudinal muscle cells were targeted, the circular muscle was removed using fine forceps. The chamber was mounted on the stage of an inverted microscope (Olympus CK-2, Tokyo, Japan). The LMMP was pinned tautly and bathed with oxygenated (95% O 2 , 5% O 2 ) Krebs solution at a flow rate of 4 ml min −1 at 37°C. The preparation was equilibrated for 40 min before commencing intracellular recordings. Single smooth muscle cells were impaled with glass microelectrodes (1 mm diameter; FHC Inc., Bowdoin, ME USA) filled with 2 M KCl (tip resistance 80-120 M ). Membrane potential was recorded using an Axoclamp 2A amplifier (Molecular Devices Corp., Sunnyvale, CA, USA) in bridge mode. Inhibitory junction potentials were evoked focally using microelectrode capillary glass (World Precision Instruments, Sarasota, FL, USA) pulled to a tip diameter of ß60 μm using a horizontal microelectrode puller (PN-31; Narishige Instruments, E. Meadow, NY, USA). The stimulating electrode (filled with Krebs solution) was positioned near the recording site, and single stimuli (4 ms duration) and short trains of stimulation (1, 5 and 10 Hz, 1 s, 45 mA), provided by a pulse generator (Master 8; AMPI, Jerusalem, Israel) and a constant-current stimulation unit (Grass Technologies, West Warwick, RI, USA) were used to evoke IJPs. The resting membrane potential (RMP) of smooth muscle cells was allowed to stabilize for 10 min. Cells with RMPs less than −40 mV were not included in the analysis. Signals were recorded using an A/D converter (Digidata 1322A; Molecular Devices), Axoscope 10 software (Molecular Devices) and a desktop computer. Amplified signals were sampled at 2 kHz and filtered at 1 kHz. We measured IJP amplitude (longitudinal muscle) and the area under the curve (AUC; circular muscle) because this is an integration of both IJP amplitude and duration. This allowed us to study the changes in responses induced by drugs. The AUCs were measured in control conditions and during drug treatment.
Drugs were dissolved in oxygenated Krebs solution and applied from an array of six quartz glass tubes (300 μm tip diameter; Polymicro Technologies, Phoenix, AZ, USA) using gravity-driven flow from a 10 ml syringe reservoir. The flow tube array was mounted on a Plexiglass platform with a flexible heating foil (Minco Inc.; www.minco.com) glued to the surface. Solutions flowing (0.1 ml min −1 ) through the tubes were warmed to 36°C before flowing into the tissue chamber. The flow tube was positioned over the recording site using a micromanipulator so that the recording site was bathed in drug-containing buffer. This technique permitted use of small volumes of toxin-containing solutions while allowing construction of steady-state concentration-response curves.
Immunohistochemical studies
Segments of guinea-pig and mouse [wild-type (WT) and Ca V 2.3 knockout] (Wilson et al. 2000) ileum were cut open along the mesenteric border, stretched and pinned flat in a silicone elastomer-lined Petri dish, which was then filled with Zamboni's fixative [2% (v/v) formaldehyde and 0.2% (v/v) saturated picric acid in PBS]. Tissues were fixed overnight (4°C) and then washed three times with DMSO at 10 min intervals, followed by three washes in PBS at 10 min intervals. Whole-mount LMMP preparations were dissected and then pre-incubated in 4% normal donkey serum in PBS for 30 min at room temperature. All primary antisera were diluted in PBS. Tissues were incubated with primary antibodies overnight at room temperature. Nitric oxide synthase immunoreactivity was localized using a sheep polyclonal antiserum (1:200 dilution, protein concentration not available from the manufacturer; Millipore, USA; catalogue no. AB1529). A rabbit polyclonal α 1E antiserum (final dilution 1.5 μg ml −1 ) was used to localize Ca V 2.3 (Alomone Laboratories, Jerusalem, Israel; catalogue no. ACC-006). The antibody was raised against the intracellular loop connecting domains II and III of the rat Ca V 2.3 protein.
After overnight incubation, unbound antibody was rinsed away with three washes of PBS at 10 min intervals. The preparations were then incubated in indocarbocyanine (Cy 3 ; 7.5 μg ml −1 in PBS) or fluorescein isothiocyanate (FITC; 37.5 μg ml −1 in PBS) conjugated secondary antibodies (Jackson Immunochemicals, West Grove, PA, USA) reconstituted in PBS for 2 h at room temperature. The tissue was washed in PBS three times at 10 min intervals and then mounted in buffered glycerol (pH 8.6) for fluorescence microscopy. Staining was viewed using a Nikon fluorescence microscope (model TE 2000-U; Nikon Corporation, Tokyo, Japan) and METAMORPH software (Molecular Devices, Sunnyvale, CA, USA) or a Leica TCS SL laser scanning confocal microscope (×40 oil immersion 1.3 n.a. objective) using a Leica DMLFSA microscope body (Leica Microsystems Inc., Buffalo Grove, IL USA). Specificity of the Ca V 2.3 antibody was verified using whole mounts of LMMP preparations from WT and α 1E KO mice (Wilson et al. 2000) .
Drugs
All drugs were obtained from Sigma-Aldrich (St Louis, MO, USA), except ω-conotoxin GVIA (ω-CTX; Alomone Laboratories). Drugs were dissolved in deionized water, with the exception of nitro-L-arginine (NLA), which was dissolved in HCl (0.1 N), and nifedipine, which was dissolved in 95% ethanol.
Data analysis
Data are presented as the mean values ± SD and n refers to the number of animals from which tissues were obtained. Data were analysed using Student's paired t test for comparison of control and single treatment effects or a one-way ANOVA followed by Bonferoni's post hoc test for control and multiple treatment effects. Drug concentration-response curves were fitted using a four-parameter (maximum, minimum, slope and EC 50 ) non-linear logistic function in GraphPad Prism 6.0 (GraphPad Software, La Jolla, CA, USA). A value of P < 0.05 was considered statistically significant.
Results
Effect of nerve stimulation
Transmural nerve stimulation (20 Hz, 1 s train duration) in LMMP preparations (in the presence of 1 μM scopolamine) precontracted with histamine (1 μM) produced a relaxation followed by a slowly developing non-cholinergic contraction in most preparations (Fig. 1A) . The relaxation and non-cholinergic contraction were blocked by tetrodotoxin (TTX; 0.3 μM; not shown). The non-selective Ca 2+ channel blocker CdCl 2 produced a concentration-dependent and complete inhibition of the relaxation (Fig. 1A) and non-cholinergic contraction (Fig. 1B) with an IC 50 value of 5.6 ± 2.9 μM (n = 6).
Nickel chloride and NLA inhibit neurogenic relaxations
At concentrations ࣘ50 μM, NiCl 2 can selectively block R-type Ca 2+ channels (Gasparini et al. 2001; Tottene et al. 2000; Wang et al. 1999; Wu et al. 1998) . We found that NiCl 2 (0.1-100 μM) caused a concentration-dependent inhibition of neurogenic LMMP relaxations ( Fig. 2A) . The NOS inhibitor NLA (0.1-100 μM) also reduced the peak relaxation with a maximal inhibition of 20 ± 12%. Co-application of NiCl 2 with NLA inhibited the relaxation amplitude by 21 ± 12%. There were no differences in the concentration-response curves for NiCl 2 , NLA or NiCl 2 with NLA for inhibition of the NANC relaxations (P > 0.05, n = 8 for all groups; Fig. 2A ).
Although NiCl 2 blocks R-type Ca 2+ channels, it could also block other Ca 2+ -dependent mechanisms to alter smooth muscle tone. Therefore, we tested the actions of NiCl 2 on cholinergic contractions of the LMMP caused by single electrical stimuli applied at 0.1 Hz (Galligan, 1993) . These responses were blocked by scopolamine (1 μM), indicating that they are mediated by acetylcholine acting at muscarinic receptors on the longitudinal muscle ( Fig. 2B ; Galligan, 1993) . Nickel chloride (1-100 μM, n = 6) did not alter cholinergic contractions, whereas CdCl 2 (1-100 μM) produced a concentration-dependent inhibition of the same responses (Fig. 2C) ; the IC 50 was 8.2 ± 3.4 μM (n = 6). We further verified the specificity of NiCl 2 for NANC relaxations by testing its effects on non-cholinergic contractions evoked by short trains of stimulation (10 Hz, 1 s) in the presence of scopolamine (1 μM) to block muscarinic receptors (Fig. 2D) . These non-cholinergic contractions are mediated predominately by substance P acting at NK-1-type receptors (Lippi et al. 1998) . Nickel chloride produced a concentration-dependent (EC 50 = 24 ± 1.9 μM, n = 3) increase in the amplitude of the non-cholinergic contractions (Fig. 2D) . Cadmium chloride (IC 50 = 35 ± 23.3 μM, n = 6) and the N-type Ca 2+ channel blocker ω-CTX (IC 50 = 6.9 ± 4.1 nM, n = 3) both inhibited the non-cholinergic contraction (Fig. 2D ).
Nickel chloride, NLA and apamin increase non-cholinergic contractions
We next tested the effect of NiCl 2 (50 μM), NLA (100 μM) and apamin (0.1 μM) on the non-cholinergic contraction (in the presence of 1 μM scopolamine), because this response was more stable than the neurogenic relaxation and permitted sequential application of drugs throughout an experiment with a long time course. In these experiments, the AUC was measured, because drug treatments increased the amplitude and duration of the contraction. Nickel chloride significantly increased the AUC ( Fig. 3A and B ; P < 0.05). Subsequent addition of NLA did not further increase the contraction, whereas addition of apamin further increased the AUC. The magnitude of this effect was statistically greater than the effect of NiCl 2 or NiCl 2 + NLA ( Fig. 3A and B ; n = 10, P < 0.05). In a second set of experiments, NLA applied first increased contraction AUC ( Fig. 3C ; P < 0.05), and addition of NiCl 2 did not produce a further increase in the contraction (P > 0.05). However, subsequent addition of apamin caused a further increase in the AUC, which was greater than the combined effect of NiCl 2 and NLA ( Fig. 3C ; P < 0.05). Finally, apamin alone increased the contraction AUC ( Fig. 3D ; P < 0.05), and addition of NLA in the presence of apamin further increased the AUC (P < 0.05). Nickel chloride did not further increase the contraction in the presence of apamin and NLA (Fig. 3D ).
Combined effect of NiCl 2 , NLA and apamin on neurogenic relaxations
The contribution of SK channels to neurogenic relaxation was examined using apamin (0.1 μM). Combined application of NiCl 2 (50 μM) and NLA (100 μM) reduced the neurogenic relaxation by 62% (Fig. 4A and B) . Cumulative addition of apamin completely blocked the neurogenic relaxation ( Fig. 4A and B) . Apamin alone reduced the relaxation by 36%, and cumulative addition A, bottom trace, the relaxation and contraction were blocked by the non-selective Ca 2+ channel blocker CdCl 2 (100 μM). B, inhibition of the relaxation by CdCl 2 was concentration dependent (n = 6). The curve was fitted to the data points using a four-parameter (maximum, minimum, slope and EC 50 ) non-linear logistic function. Abbreviation: NANC, non-adrenergic, non-cholinergic.
E. S. Rodriguez-Tapia and others
of NLA with NiCl 2 completely blocked the relaxation (Fig. 4C) .
Actions of Ca 2+ channel blockers and a P2Y 1 receptor antagonist on neurogenic relaxations
The data above show that the neurogenic relaxation is apamin sensitive, and previous work has shown that purinergic receptors link to the Ca 2+ -activated SK channel activation in gut smooth muscle (De Man et al. 2003; Gallego et al. 2006; Zhang et al. 2010) . In the next experiment (in the presence of 1 μM scopolamine), we used MRS 2179 to block P2Y 1 purinergic receptors (Baurand et al. 2001; Boyer et al. 1998) but, in contrast to our expectations, we found that MRS 2179 had no effect on the amplitude of the neurogenic relaxation (Fig. 5A ). Cumulative addition of NLA reduced the neurogenic relaxation, and subsequent addition of apamin further reduced the relaxation, although this was not statistically different from the effect of NLA (P > 0.05). Nitro-L-arginine inhibited the neurogenic relaxation by 61%, and cumulative addition of NiCl 2 (50 μM) and ω-CTX (0.1 μM) did not produce any further inhibition (Fig. 5B) . In another set of experiments, MRS 2179 applied first did not affect the neurogenic relaxation, and cumulative addition of NiCl 2 also did not reduce the relaxation. However, further addition of ω-CTX inhibited the relaxation by 62% (Fig. 5C ). In the last set of these experiments, MRS 2179 did not affect the neurogenic relaxation, but further addition of ω-CTX reduced the relaxation by 52% (P < 0.05) and further addition of NiCl 2 reduced the relaxation by 40% (P < 0.05; Fig. 5D ). , 1 s) . The control relaxation was ß40% of histamine-induced tone. This relaxation was reduced by ß50% by NLA or NiCl 2 . Combined application of NiCl 2 and NLA did not produce a greater inhibition then either drug alone (n = 8 for all groups). B, representative recording of contractions of the LMMP evoked by single electrical stimuli. Addition of NiCl 2 did not affect contraction amplitude, while subsequent addition of the muscarinic receptor antagonist scopolamine blocked these contractions completely, confirming that they were mediated by nerve-released acetylcholine. C, NiCl 2 did not inhibit LMMP contractions caused by single shocks (0.1 Hz, n = 6). Cadmium chloride produced a concentration-dependent inhibition of the neurogenic cholinergic contraction (n = 6). D, the N-type Ca 2+ channel blocker ω-conotoxin GVIA (ω-CTX; n = 3) and CdCl 2 (n = 6) blocked non-cholinergic contractions of the LMMP (20 Hz, 1 s, in the presence of 1 μM scopolamine). Nickel chloride produced a concentration-dependent increase in the amplitude of the non-adrenergic, non-cholinergic (NANC) contraction (n = 3). R-Type Ca 2+ channels in enteric nervous system
Longitudinal muscle IJPs are NiCl 2 sensitive
Focal stimulation (10 Hz, 1 s) was used to evoke IJPs in longitudinal smooth muscle cells. The IJP was followed by a non-cholinergic (in the presence of 1 μM scopolamine) excitatory junction potential (EJP; Fig. 6A ). Nickel chloride (50 μM) inhibited the IJP by ß50% but did not affect the EJP (Fig. 6A-C) . MRS 2179 (10 μM) did not affect the IJP but reduced EJP amplitude by ß45% ( Fig. 6D and E) .
Circular muscle IJPs are NiCl 2 insensitive
Focal stimulation (10 Hz, 1 s) was used to evoke circular muscle IJPs, which were blocked by TTX (0.3 μM), MRS 2179 (10 μM) and apamin (0.1 μM; Fig. 7A ). Cadmium chloride produced a concentration-dependent inhibition of circular muscle IJPs (IC 50 = 24 ± 2.2 μM), as did the N-type Ca 2+ channel blocker ω-CTX (IC 50 = 0.03 ± .02 μM). Nickel chloride (up to 50 μM) did not alter the circular muscle IJP (Fig. 7B) . We also used 5 Hz stimulation to evoke more slowly developing IJPs that might reveal a nitrergic component (Fig. 7C ).
However, neither NiCl 2 alone nor in combination with NLA changed the amplitude or time course of the IJP. The 5 Hz IJPs were inhibited significantly by apamin (Fig. 7D) .
Localization of the α 1E subunit of Ca V 2.3 in guinea-pig ileum
Immunohistochemical studies revealed α 1E immunoreactivity in varicose nerve fibres in myenteric ganglia and in the tertiary plexus that supplies the longitudinal muscle layer (Fig. 8A ). Preparations were co-stained with the α 1E antibody and an nNOS antibody. The α 1E and nNOS immunoreactivities were co-localized in nerve fibres in the tertiary plexus (Fig. 8B-D) . The α 1E and nNOS immunorectivities were expressed in separate populations of nerve fibres in the deep muscular plexus supplying the circular muscle layer (Fig. 8E-G) . We tested the specificity of the antibody for the α 1E protein in whole mounts of WT and α 1E KO mouse colon. The antibody revealed bright varicose nerve fibres that appeared to encircle nerve cell bodies in myenteric ganglia in tissues from WT mice (Fig. 8H) . We did not detect prominent α 1E -positive 
Figure 3. Potentiation of LMMP non-cholinergic contractions
A, non-cholinergic contractions (in the presence of 1 μM scopolamine) were evoked by a train of nerve stimulation (ns; 20 Hz, 1 s). Nickel chloride (50 μM) increased the peak amplitude and duration, and subsequent addition of NLA (100 μM) did not produce any further increase. However, addition of the SK channel blocker apamin (0.1 μM) further increased contraction amplitude and duration. B, quantitative data for the experiment illustrated in A. C, data from an experiment similar to that shown in A except the sequence of drug application was altered, with NLA application preceding NiCl 2 followed by apamin. Nitro-L-arginine increased the contraction, and addition of NiCl 2 did not increase the contraction further. Apamin did produce an additional increase in contraction amplitude and duration. D, the sequence of drug application was apamin followed by addition of NLA followed by addition of NiCl 2 . Apamin and then NLA produced a sequential increase in the contraction, but NiCl 2 did not produce a further increase. For all figures, * P < 0.05, n = 10 for each experiment. All data were analysed by one-way ANOVA and Tukey's post hoc test.
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nerve fibres in the longitudinal muscle in preparations from WT mice. We also did not detect varicose nerve fibres in myenteric ganglia in tissues from α 1E KO mice (Fig. 8I ).
Discussion
R-Type Ca 2+ channels couple to NOS activation N-Type Ca 2+ channels contribute to release of excitatory and inhibitory neuromuscular transmitters throughout the GI tract (Wilson et al. 2000) . However, we have identified selective contributions of R-type Ca 2+ channels to NO-mediated inhibitory neuromuscular transmission to the longitudinal muscle layer in the guinea-pig ileum. We used NiCl 2 as a tool to test the function of R-type Ca 2+ channels because it blocks these channels selectively at concentrations ࣘ50 μM (Wu et al. 1998; Wang et al. 1999; Tottene et al. 2000; Gasparini et al. 2001) . In histamine-precontracted and scopolamine-treated tissues, electrical field stimulation caused transient relaxations followed by a non-cholinergic contraction. Both responses were blocked by TTX, indicating that they were neurogenic, and by the non-selective Ca 2+ channel subtype blocker CdCl 2 . As shown previously in the guinea-pig ileum LMMP, the NOS inhibitor NLA produces a concentration-dependent but incomplete inhibition of the neurogenic relaxation (Osthaus & Galligan, 1992) . Nickel chloride produced a similar inhibitory effect on the neurogenic relaxation, whereas combined application of NiCl 2 and NLA did not produce an effect that differed from either blocker alone. These data suggest that NiCl 2 and NLA act on a common mechanism to inhibit neurogenic relaxations of the longitudinal muscle.
Although NiCl 2 is a potent inhibitor of R-type Ca 2+ channels, it is possible that NiCl 2 could directly alter muscle contractility by blocking other cation channels or that it blocks other Ca 2+ -permeable channels. However, Talukder & Harrison (1995) found that NiCl 2 at concentrations up to 200 μM did not alter K + currents recorded from hippocampal neurons. There are also studies demonstrating that R-type Ca 2+ channels are expressed by vascular smooth muscle cells (Link et al. 2008; Bkaily et al. 2015) , so NiCl 2 could directly affect longitudinal muscle contractility. We addressed this issue by studying the actions of NiCl 2 on neurogenic contractions caused by single electrical stimuli of the LMMP in the absence of scopolamine. These contractions are mediated by acetylcholine acting at muscarinic receptors on the longitudinal muscle (Osthaus & Galligan, 1 μM) on the neurogenic relaxation. B, quantification of data for the experiment illustrated in A. Control relaxation was ß60% of histamine-induced tone. Addition of NLA/NiCl 2 caused ß30% reduction of the peak relaxation amplitude, and cumulative addition of apamin abolished the remaining response (n = 7; * P < 0.05). C, similar experiment to that shown in A and B, but apamin was applied first. Apamin produced 21% reduction of peak relaxation amplitude, and this effect was significant when compared with the control (n = 12; * P < 0.05). Cumulative application of NLA/NiCl 2 abolished the apamin-resistant relaxation ( * P < 0.05). All data were analysed by one-way ANOVA and Tukey's post hoc test. R-Type Ca 2+ channels in enteric nervous system 1992). Nckel chloride did not alter the cholinergic contraction, whereas CdCl 2 blocked this response. In addition, NiCl 2 enhanced non-cholinergic neurogenic contractions of the longitudinal muscle. These data indicate that NiCl 2 does not have general inhibitory effects on neurotransmitter release or muscle contractility. It is possible that NiCl 2 could interact directly with NOS to inhibit its function. Studies in brain homogenates revealed that NiCl 2 can directly inhibit nNOS activity (Mittal et al. 1995) . However, in these studies, nNOS inhibition occurred only at very high NiCl 2 concentrations, as the K i value for NiCl 2 acting directly on nNOS was 360 μM. This is more than sevenfold higher than the concentrations of NiCl 2 used in our studies to inhibit neurogenic relaxations, and therefore, direct inhibition of nNOS is unlikely to account for NiCl 2 -induced inhibition of neurogenic relaxations in our studies. We found that the non-cholinergic contraction increased in amplitude and duration in the presence of NiCl 2 and NLA. As NiCl 2 and NLA reduced inhibitory neuromuscular transmission, simultaneous excitatory responses would be enhanced. We used the enhanced non-cholinergic contraction as an additional test for coincident sites of action of NiCl 2 and NLA on neuromuscular transmission. We also varied the sequence of drug application. Nickel chloride and NLA alone each increased the NANC contraction, but the effects of these blockers were not additive. However, subsequent addition of apamin caused a further increase in the NANC contraction. Likewise, apamin alone increased the NANC did not affect the neurogenic relaxation, whereas NLA (100 μM) inhibited the relaxation ( * P < 0.05 versus control and MRS 2179). Apamin (0.1 μM) produced a further reduction in relaxation amplitude, although this was not different from NLA alone ( * P < 0.05 versus control and MRS 2179, n = 7). B, NLA alone inhibited the neurogenic relaxation, and cumulative application of NiCl 2 and ω-CTX (0.1 μM) did not produce any further inhibition of the relaxation ( * P < 0.05 versus control). C, cumulative addition of MRS 2179 followed by NiCl 2 did not alter the neurogenic relaxation, whereas subsequent addition of ω-CTX reduced the relaxation by ß52% ( * P < 0.05 versus NiCl 2 , n = 7). D, MRS 2179 did not inhibit the neurogenic relaxation, but subsequent cumulative application of ω-CTX reduced the relaxation by 56% and cumulative addition of NiCl 2 reduced the relaxation by an additional 40% ( * P < 0.05, n = 7). All data were analysed by one-way ANOVA and Tukey's post hoc test. In these experiments, the y-axis represents the percentage of the control (maximal) relaxation (in the absence of antagonist drugs), as the percentage relaxation normalized to histamine-induced tone was >100% in some tissues.
E. S. Rodriguez-Tapia and others contraction, with either NiCl 2 or NLA producing a further increase. These data indicate that NiCl 2 and NLA act at a shared target (nNOS), while apamin further increased the NANC contraction by blocking SK channels on the muscle. These are non-overlapping pathways causing smooth muscle relaxation. Our data show that ω-CTX partly inhibits the neurogenic relaxation of longitudinal muscle, as has also been shown for the guinea-pig taenia coli preparation (Lundy & Frew, 1994) and canine ileocolonic circular muscle (Boeckxstaens et al. 1993) . We also found that addition of NiCl 2 further reduces this response, indicating that release of transmitters from longitudinal muscle inhibitory motoneurons is under dual control by N-and R-type Ca 2+ channels. Localization of R-type Ca 2+ channels to longitudinal muscle inhibitory motoneurons is further supported by our immunohistochemical data showing that immunoreactivity to the α 1E Ca 2+ channel subunit (R-type Ca 2+ channel protein subunit) is co-localized with nNOS immunoreactivity in the tertiary plexus that provides the innervation of the longitudinal muscle layer. These data also show expression of the α 1E subunit in varicose nerve fibres in myenteric ganglia. This observation is consistent with our previous results showing that R-type Ca 2+ channels contribute to fast synaptic transmission in the myenteric plexus (Naidoo et al. 2010) . These data support a role for R-type Ca 2+ channels in synaptic and neuromuscular transmission in the guinea-pig small intestine.
R-Type Ca
2+ channels link to release of the mediator of IJPs recorded from longitudinal but not circular smooth muscle
The data discussed above indicate that R-type Ca 2+ channels provide the Ca 2+ needed for nNOS activation in longitudinal muscle inhibitory motoneurons but not for purine release, which is required for apamin-sensitive SK channel activation. This issue was addressed more C, NiCl 2 does not inhibit the EJP (n = 5). D, the P2Y 1 receptor antagonist MRS 2179 did not alter the IJP but reduced the EJP by ß50% (E) (n = 6). All data in this figure were analysed using Student's paired t test ( * P < 0.05 versus control). R-Type Ca 2+ channels in enteric nervous system directly by studying IJPs recorded from smooth muscle cells. Nickel chloride partly inhibited IJPs recorded from longitudinal smooth muscle cells, whereas the P2Y 1 receptor antagonist MRS 2179 had no effect on these IJPs. This result is not consistent with a model where there are dual mediators of neurogenic relaxation, the NiCl 2 /LNA-sensitive NO-mediated component and the apamin-sensitive, presumably purine mediated component. However, there are likely to be multiple purinergic inhibitory neuromuscular transmitters, and their actions might be differentially sensitive to P2Y 1 receptor antagonists (Mutafova-Yambolieva et al. 2007) . For example, hyperpolarization of murine, human and monkey colonic smooth muscle caused by β-NAD and nerve stimulation is blocked by a P2Y 1 receptor antagonist, whereas hyperpolarization caused by ATP is not (Hwang et al. 2001; Mutafova-Yambolieva et al. 2007 ). The specific purine responsible for the fast IJP in guinea-pig ileum longitudinal muscle might be a purine whose actions are not altered by MRS 2179. Others have shown that ATP acting at purinergic receptors may be an excitatory neurotransmitter in the guinea-pig longitudinal muscle layer (Ivancheva et al. 2000) . Our data support this hypothesis, as we show that the EJP recorded from longitudinal muscle cells is inhibited by MRS 2179. Interestingly, in the longitudinal muscle of the guinea-pig distal colon, stretch-and distention-evoked IJPs are blocked by NOS inhibitors, suggesting that fast IJPs do not occur in the longitudinal muscle layer of the guinea-pig distal colon (Spencer & Smith, 2001; Spencer et al. 2003) . Inhibitory junction potentials recorded from circular muscle were blocked completely by MRS 2179 and apamin. The circular muscle IJPs were also blocked by ω-CTX, indicating that N-type Ca 2+ channels are responsible for release of the mediator(s) of the IJP, as also occurs in the circular muscle of the canine ileum (Cayabyab et al. 1997) , porcine ileum (Borderies et al. 1997 ) and rat colon (Borderies et al. 1996) . Zagorodnyuk & Maggi (1994) found apamin-resistant and E. S. Rodriguez-Tapia and others apamin-sensitive IJPs in guinea-pig colon circular muscle cells. The apamin-sensitive but not apamin-insensitive IJPs were blocked by ω-CTX, and the apamin-resistant IJP was attributed to the actions of NO. We did not detect apamin-resistant nitergic IJPs, but we did find that the apamin-sensitive IJPs were blocked by ω-CTX and by MRS 2179, indicating that release of the purinergic transmitter is dependent only on N-type Ca 2+ channels. Nitric oxide causes smooth muscle relaxation by K + channel-dependent and -independent mechanisms. K + channel-independent mechanisms include protein kinase G-mediated suppression of Ca 2+ release from the endoplasmic reticulum and inhibition of smooth muscle phosphodiesterases (Makhlouf & Murthy, 1997; De Man et al. 2007 ). These non-K + channel mechanisms could mediate the apamin-resistant IJPs. We did detect α 1E immunoreactivity in nerve fibres supplying the circular muscle layer and we did not detect NOS immunoreactivity in these nerve fibres. In addition, the circular muscle IJPs were not affected by NiCl 2 . It is possible that the Our data show that R-type Ca 2+ channels couple to NOS activation and NO release, whereas N-type Ca 2+ channels control the release of a purine transmitter to cause GI smooth muscle relaxation in the guinea-pig ileum. The current model of the nerve supply of the longitudinal muscle layer indicates that there is only one class of inhibitory neuron identified by NOS immunostaining (Brookes, 2001) . Therefore, longitudinal muscle inhibitory motoneurons should release NO and a purine to cause muscle relaxation. However, our data suggest that there might be two classes of longitudinal muscle inhibitory motoneurons in the guinea-pig, where one class uses NO as the transmitter, whereas the second class is purinergic. R-Type Ca 2+ channels are localized to nitrergic nerve terminals, whereas N-type channels are localized to purinergic nerve terminals. We localized α 1E immunoreactivity (R-type Ca 2+ channel subunit) in myenteric ganglia, and α 1E immunoreactivity co-localized with NOS immunoreactivity in individual nerve varicosities in the tertiary plexus that supplies the longitudinal muscle. α 1E -positive nerve fibres were detected in the myenteric plexus of the mouse colon but not in the muscle layers. There are likely to be species differences in the localization and function of R-type Ca 2+ channels in the enteric nervous system. We used the colon from an α 1E KO mouse (Wilson et al. 2000) to check the specificity of the α 1E antibody, and α 1E -positive nerve fibres were not detected in colon preparations from these mice.
Unfortunately, there are no reliable markers available for purinergic nerve fibres in the ENS, although the vesicular nucleotide transporter (VNUT, SLC17A9) may prove to be the needed marker (Sawada et al. 2008) . Immunohistochemical studies using a VNUT antibody would provide a direct test of the hypothesis that there are separate classes of inhibitory neurons supplying the longitudinal muscle. We also found that R-type Ca 2+ channels do not contribute to IJPs in the circular muscle. However, R-type Ca 2+ channels may contribute to nitrergic and/or excitatory neurotransmission to the circular muscle, which was not addressed in our study.
Summary and conclusions
Our data support a model in which R-type Ca 2+ channels couple to NOS activation and NO release from nerve fibres supplying the longitudinal muscle layer. N-Type Ca 2+ channels contribute to non-nitrergic, purinergic inhibitory neuromuscular transmission. Separate control of the release of inhibitory neuromuscular transmitters provides an additional level of modulation of muscle tone and also provides a safety factor that ensures inhibitory neurotransmission is maintained if one mechanism is compromised.
